Ginkgo Bioworks Holdings Inc (DNA) Live Share Price, Invest From India

Ginkgo Bioworks Holdings Inc Stock Performance

as on February 11, 2026 at 7:59 am IST

Day's Low
Day's High
$9.18
Day's Price Range
$10.38
$9.24
0.65%
Downside
12.34%
Upside
52 Week's Low
52 Week's High
$5.00
52-Week Price Range
$17.58
$9.24
45.89%
Downside
90.26%
Upside

Ginkgo Bioworks Holdings Inc share price movements today

Previous Close: $10.15
Open: $10.07
Volume: 988.0K
Day's Low - High: $9.18 - $10.38
52 Week Low - High: $5.00 - $17.58

Ginkgo Bioworks Holdings Inc Historical Returns

1 Month Return: + 9.85 %
3 Month Return: + 15.74 %
1 Year Return: -24.93 %
3 Year Return: -85.33 %
5 Year Return: 0 %

Ginkgo Bioworks Holdings Inc Stock Fundamentals & Key Indicators

Check Ginkgo Bioworks Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$596.8M

EPS (TTM)

-5.34

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-13.62

Industry PE ratio

13.46195652173913

PEG Ratio

EBITDA

-271.9M

Revenue (TTM)

180.6M

Profit Margin

-188.00%

Return On Equity TTM

-50.02%

Ginkgo Bioworks Holdings Inc Stock Valuation

Track how Ginkgo Bioworks Holdings Inc P/E has moved over time to understand its valuation trends.

Ginkgo Bioworks Holdings Inc in the last 5 years

Overview
Trends

Lowest (-177.66x)

September 30, 2023

Today (-13.62x)

February 10, 2026

Industry (13.46x)

February 10, 2026

Highest (-1.32x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -13.62x

Ginkgo Bioworks Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ginkgo Bioworks Holdings Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Ginkgo Bioworks Holdings Inc	SELL	$596.8M	NA	-13.62	-188.00%
Vertex Pharmaceuticals Incorporated	BUY	$122.3B	121.55%	33.56	31.35%
Alnylam Pharmaceuticals, Inc.	BUY	$47.7B	94.93%	1246.03	1.36%
Beone Medicines Ltd	NA	$37.4B	NA	662.33	1.38%
Regeneron Pharmaceuticals, Inc.	BUY	$80.8B	58.85%	18.28	32.13%

Stock Returns calculator for Ginkgo Bioworks Holdings Inc Stock including INR - Dollar returns

The Ginkgo Bioworks Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Ginkgo Bioworks Holdings Inc investment value today

Current value as on today

₹71,862

Returns

₹28,138

(-28.14%)

Returns from Ginkgo Bioworks Holdings Inc Stock

₹31,657 (-31.66%)

Dollar Returns*

₹3,519 (+3.52%)

Analyst Recommendation on Ginkgo Bioworks Holdings Inc Stock

Based on 14 analysts

SELL

7.14%

Buy

42.86%

Hold

50.00%

Sell

Based on 14 analysts, 50% of analysts recommend a 'SELL' rating for Ginkgo Bioworks Holdings Inc. Average target price of $10

Ginkgo Bioworks Holdings Inc Share Price Target

Get share price movements and forecasts by analysts on Ginkgo Bioworks Holdings Inc.

What analysts predicted

7.6%UPSIDE

Target Price

$10

Current Price

$9.24

Analyzed by

14 Analysts

Target

$10.00

Ginkgo Bioworks Holdings Inc target price $10, a slight upside of 7.6% compared to current price of $9.24. According to 14 analysts rating.

Ginkgo Bioworks Holdings Inc Stock’s Investor Sentiment and Interest

Investment in Ginkgo Bioworks Holdings Inc Shares on INDmoney has grown by 8.98% over the past 30 days, indicating increased transactional activity.

Time period: January 12, 2026 to February 11, 2026

Change:8.98% versus previous 30 day period

Search interest for Ginkgo Bioworks Holdings Inc Stock has decreased by -3% in the last 30 days, reflecting a downward trend in search activity.

Time period: January 12, 2026 to February 11, 2026

Change:-3% versus previous 30 day period

Ginkgo Bioworks Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	80	55	34	37	56	89	43	48	49	38
Gross Profit	62	48	28	28	42	79	34	36	34	26
Operating Income	-184	-286	-178	-178	-222	-55	-103	-88	-65	-90
EBITDA	-166	-169	-288	-165	-140	-35	-143	-68	-46	-66
Interest Expense	-	-	0	-	-	-	0	-	-	-
Depreciation	18	20	13	12	17	17	15	15	15	14
Income Before Tax	-173	-302	-211	-165	-216	-56	-107	-90	-60	-80
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-173	-302	-211	-165	-217	-56	-107	-90	-60	-80
Net Profit Margin	-215.12%	-546.44%	-609.10%	-437.25%	-386.40%	-63.34%	-245.25%	-188.25%	-121.56%	-207.93%

Ginkgo Bioworks Holdings Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	54	76	313	477	251	227
Gross Profit	54	61	184	273	197	188
Operating Income	-71	-137	-1,828	-2,208	-864	-559
EBITDA	-106	-108	-1,806	-2,059	-821	-484
Interest Expense	2	2	2	0	0	0
Depreciation	10	13	29	44	75	63
Income Before Tax	-119	-124	-1,838	-2,121	-892	-547
Income Tax Expense	0	1	-1	-15	0	0
Net Income	-119	-126	-1,830	-2,104	-892	-547
Net Profit Margin	-220.23%	-165.16%	-583.12%	-440.63%	-355.08%	-240.94%

Ginkgo Bioworks Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-302	-211	-165	-217	-56	-107	-90	-60	-80
Operating Cash Flow	-73	-57	-89	-84	-103	-42	-51	-40	-31
Investing Cash Flow	-3	-46	-12	-26	-10	-13	-198	-63	-72
Financing Cash Flow	0	0	0	0	0	0	0	0	9
Change in Cash	-77	-103	-105	-111	-113	-55	-250	-105	-94

Ginkgo Bioworks Holdings Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-126	-1,836	-2,106	-892	-547
Operating Cash Flow	-135	-253	-252	-295	-319
Investing Cash Flow	-67	-73	-67	-80	-62
Financing Cash Flow	90	1,534	95	-3	-1
Change in Cash	-112	1,207	-223	-379	-383

Global Institutional Holdings in Ginkgo Bioworks Holdings Inc

Funds	Holdings
Vanguard Group Inc	4.02%
Millennium Management LLC	2.29%
Forbes J M & Co	1.82%
SB INVESTMENT ADVISERS (UK) LTD	1.03%
Ensign Peak Advisors Inc	0.56%

See all

Insights on Ginkgo Bioworks Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, DNA stock has moved up by 15.5%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 58.8% return, outperforming this stock by 83.7%
NO EFFECT
Against Peers
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 42.7% return, outperforming this stock by 128.0%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 49.60M → 38.83M (in $), with an average decrease of 21.7% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -60.3M → -80.75M (in $), with an average decrease of 33.9% per quarter

About Ginkgo Bioworks Holdings Inc

the organism company ginkgo bioworks engineers new organisms to solve challenges across a range of industries from fuels to pharmaceutical production. our biological engineers make use of an in-house pipeline of synthetic biology technologies to design, build, and test new organisms.

Organisation	Ginkgo Bioworks Holdings Inc
Headquarters	27 Drydock Avenue, Boston, MA, United States, 02210
Industry	Healthcare
CEO	Dr. Jason Kelly Ph.D.
E-voting on shares	Click here to vote

Key Management of Ginkgo Bioworks Holdings Inc

Name	Title
Dr. Reshma P. Shetty	President & Director
Mr. Austin Che Ph.D.	Founder, Head of Strategy & Treasurer
Mr. Steven P. Coen CPA	Chief Accounting Officer & CFO
Mr. Daniel Marshall	Senior Manager of Communications & Ownership
Ms. Samantha Sutton	Head of People
Dr. Jason Kelly Ph.D.	Founder, Co-COO, CEO & Director
Mr. Thomas Knight Jr.	Founder
Mr. Bartholomew Canton Ph.D.	Founder, CTO & Secretary
Ms. Jennifer Wipf	Co-Chief Operating Officer
Ms. Karen Tepichin	General Counsel & Secretary

FAQs

What is Ginkgo Bioworks Holdings Inc share price today?

Ginkgo Bioworks Holdings Inc share price today is $9.24 as on February 11, 2026 at 2:29 am IST at the close of the market. Ginkgo Bioworks Holdings Inc share today touched a day high of $10.38 and a low of $9.18.

What is the 52 week high and 52 week low for Ginkgo Bioworks Holdings Inc share?

Ginkgo Bioworks Holdings Inc share touched a 52 week high of $17.58 on October 8, 2025 and a 52 week low of $5 on April 4, 2025. Ginkgo Bioworks Holdings Inc stock price today i.e. February 11, 2026 at 2:29 am IST is closed at $9.24,which is 47.44% down from its 52 week high and 84.80% up from its 52 week low.

What is Ginkgo Bioworks Holdings Inc's market capitalisation today?

Ginkgo Bioworks Holdings Inc market capitalisation is $0.00T as on February 11, 2026 at 2:29 am IST.

How to invest in Ginkgo Bioworks Holdings Inc Stock (DNA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ginkgo Bioworks Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ginkgo Bioworks Holdings Inc Shares that will get you 0.1623 shares as per Ginkgo Bioworks Holdings Inc share price of $9.24 per share as on February 11, 2026 at 2:29 am IST.

What is the minimum amount required to buy Ginkgo Bioworks Holdings Inc Stock (DNA) from India?

Indian investors can start investing in Ginkgo Bioworks Holdings Inc (DNA) shares with as little as ₹90.552 or $1 (as of February 11, 2026 at 3:52 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹905.52 in Ginkgo Bioworks Holdings Inc stock (as per the Rupee-Dollar exchange rate as on February 11, 2026 at 3:52 am IST). Based on Ginkgo Bioworks Holdings Inc share’s latest price of $9.24 as on February 11, 2026 at 2:29 am IST, you will get 1.0823 shares of Ginkgo Bioworks Holdings Inc. Learn more about fractional shares .